Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey […]
Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a […]
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device
The Acclaim® Fully Implanted Cochlear Implant is differentiated from existing cochlear implants and may offer new option for hearing loss […]
Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024
BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]
TSX News -
Bombardier’s Must-Attend Safety Standdown Seminar Set to Open in Wichita, KS, Incites Aviation Professionals to Elevate their Influence
Under the theme “Elevate your Influence,” free-to-attend safety event provides life-long learning opportunities for a wide cross-section of industry influencers […]
Credicorp Ltd.: Credicorp Ltd. to acquire remaining 50% stake in joint venture with Empresas Banmédica
Lima, Nov. 01, 2024 (GLOBE NEWSWIRE) — Lima, PERU, November 1st, 2024 – Credicorp Ltd. (“Credicorp”) (NYSE: BAP | BVL: BAP), […]
Stardust Power Announces Third Quarter 2024 Earnings Release Date, Conference Call
GREENWICH, Conn., Nov. 01, 2024 (GLOBE NEWSWIRE) — Stardust Power Inc. (NASDAQ: SDST) (“Stardust Power” or the “Company”), an American […]
Blue Moon Appoints Christian Kargl-Simard as CEO and Frances Kwong as CFO, as well as Garfield MacVeigh and Christian Aramayo as Advisors to the Board
VANCOUVER, British Columbia, Nov. 01, 2024 (GLOBE NEWSWIRE) — Blue Moon Metals Inc. (the “Company” or “Blue Moon”) (TSX-V: MOON, […]
Costamare Inc. Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
MONACO, Nov. 01, 2024 (GLOBE NEWSWIRE) — Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results […]
Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results
Reports record third quarter 2024 revenue of $7.6 million, representing growth of 24% compared to the third quarter of 2023 […]
